Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Effects of Sildenafil on CFTR-dependent Ion Transport Activity

NCT01132482 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT01132482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01132482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Effects of Sildenafil on CFTR-dependent Ion Transport Activity
Lead sponsor
National Jewish Health
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
May 31, 2017
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis